Clinical Trials Logo
  1. Home
  2. Mitochondrial Disease
  3. NCT00786539

Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases

Mitochondrial Disease Clinical Trial

Official title:
Investigation of the Nature and Prevalence of Mitochondria Disease

Clinical Trial Summary

The objective of this research protocol is to continue investigation of the nature and prevalence of mitochondria disease and to aid patients and health care providers in the understanding of these complex disorders. This research study brings together many clinical sub-specialists to address the etiology of these disorders and to develop more effective approaches for their diagnoses and more reliable prognoses.

Clinical Trial Description

The non-invasive device named Diffuse Optical Spectroscopy developed at the Beckman Laser Institute is to be used to measure various physiological parameters. Since mitochondria produce most of the energy necessary for cellular function, their efficacy is most important for systems with a high energy demand like the brain, heart, skeletal muscle, kidney, liver, and endocrine tissues. As a result, mitochondria diseases usually manifest as complex, multi-organ disorders, requiring multispecialty investigations. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00786539
Study type Observational
Source University of California, Irvine
Contact
Status Completed
Phase
Start date October 2006
Completion date May 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT02311257 - Survey on Supplement Use in Mitochondrial Disease N/A
Terminated NCT01001585 - Anesthetic Effects in Mitochondrial Disease N/A
Completed NCT01642056 - EPI-743 for Metabolism or Mitochondrial Disorders Phase 1/Phase 2
Recruiting NCT04419870 - Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic
Active, not recruiting NCT02000284 - Mitochondrial Dysfunction in Autism Spectrum Disorder
Completed NCT04643249 - Drug-drug Interaction Study of KL1333 in Healthy Subjects Phase 1
Completed NCT02544217 - A Dose-escalating Clinical Trial With KH176 Phase 1
Completed NCT02154711 - Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
Completed NCT01264471 - Mechanisms of Mitochondrial Defects in Gulf War Syndrome N/A
Completed NCT00829270 - Economic and Medical Evaluation of the Whole Mitochondrial DNA Screening by Surveyor and Mitochips Techniques N/A
Completed NCT02745938 - GDF-15 as a Biomarker for Mitochondrial Disease N/A
Enrolling by invitation NCT01803906 - Tissue Sample Study for Mitochondrial Disorders
Completed NCT01776918 - Energy Requirements in Mitochondrial Disease N/A
Completed NCT01301235 - Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy N/A
Completed NCT02985710 - Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan N/A
Recruiting NCT05241262 - Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels Phase 1
Completed NCT02678637 - Calf Muscle Strength in Mitochondrial Diseases N/A